Search
Back to Search

Afrezza

Afrezzza from Mannkind Corporation

Afrezza (insulin human) Inhalation Powder is the only ultra rapid-acting inhaled insulin indicated to improve glycemic management in people with diabetes ages 6 and older. Available by prescription only. 

For complete information, visit Afrezza

Afrezza insulin inhaler
Afrezza insulin inhaler with doses of 4, 8 & 12 units

Automatic Correction Boluses:

No

Closed Loop Functionality:

No

Calibration Not Required:

Yes

Medicare Covered:

Yes

Remote Software Update Capability:

No

Multiple Languages:

No

Food Database:

No

Additional Features:

 

 

Approved For Ages:

6 years and older

Tubeless:

Yes

Ask danatech!

The Danatech Digest

Join 25,000+ professionals who get our latest diabetes technology updates

DISCLAIMERS: 

This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.

ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.

danatech is Made Possible by Grant Funding and Industry Sponsorship